T. Rowe Price Associates’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $686M | Sell |
2,572,843
-3,697,370
| -59% | -$1.02B | 0.08% | 201 |
|
|
2025
Q4 | $1.73B | Sell |
6,270,213
-5,032,153
| -45% | -$1.41B | 0.19% | 100 |
|
|
2025
Q3 | $3.26B | Buy |
11,302,366
+1,008,534
| +10% | +$298M | 0.35% | 45 |
|
|
2025
Q2 | $3.4B | Sell |
10,293,832
-1,762,974
| -15% | -$568M | 0.39% | 41 |
|
|
2025
Q1 | $3.97B | Buy |
12,056,806
+1,094,327
| +10% | +$330M | 0.49% | 36 |
|
|
2024
Q4 | $3.03B | Sell |
10,962,479
-1,117,751
| -9% | -$356M | 0.35% | 44 |
|
|
2024
Q3 | $4.19B | Sell |
12,080,230
-316,628
| -3% | -$109M | 0.48% | 37 |
|
|
2024
Q2 | $4.1B | Sell |
12,396,858
-1,944,375
| -14% | -$670M | 0.49% | 34 |
|
|
2024
Q1 | $5.21B | Buy |
14,341,233
+867,180
| +6% | +$285M | 0.64% | 22 |
|
|
2023
Q4 | $4.03B | Sell |
13,474,053
-238,784
| -2% | -$69.8M | 0.54% | 27 |
|
|
2023
Q3 | $3.92B | Sell |
13,712,837
-144,807
| -1% | -$41.3M | 0.57% | 26 |
|
|
2023
Q2 | $3.89B | Buy |
13,857,644
+995,817
| +8% | +$259M | 0.54% | 29 |
|
|
2023
Q1 | $3.29B | Sell |
12,861,827
-794,781
| -6% | -$232M | 0.49% | 44 |
|
|
2022
Q4 | $4.52B | Sell |
13,656,608
-845,837
| -6% | -$268M | 0.73% | 24 |
|
|
2022
Q3 | $4.02B | Sell |
14,502,445
-1,215,679
| -8% | -$342M | 0.66% | 29 |
|
|
2022
Q2 | $4.14B | Sell |
15,718,124
-1,849,668
| -11% | -$477M | 0.52% | 32 |
|
|
2022
Q1 | $4.21B | Sell |
17,567,792
-393,540
| -2% | -$92.1M | 0.42% | 38 |
|
|
2021
Q4 | $4.12B | Buy |
17,961,332
+597,424
| +3% | +$127M | 0.37% | 46 |
|
|
2021
Q3 | $3.48B | Sell |
17,363,908
-6,744,981
| -28% | -$1.47B | 0.33% | 60 |
|
|
2021
Q2 | $5.72B | Sell |
24,108,889
-4,058,870
| -14% | -$1.01B | 0.53% | 32 |
|
|
2021
Q1 | $6.81B | Sell |
28,167,759
-1,711,626
| -6% | -$382M | 0.68% | 21 |
|
|
2020
Q4 | $6.21B | Buy |
29,879,385
+122,245
| +0.4% | +$24M | 0.64% | 25 |
|
|
2020
Q3 | $5.04B | Sell |
29,757,140
-1,415,835
| -5% | -$249M | 0.58% | 26 |
|
|
2020
Q2 | $5.85B | Buy |
31,172,975
+1,767,040
| +6% | +$335M | 0.74% | 20 |
|
|
2020
Q1 | $5.21B | Buy |
29,405,935
+4,758,978
| +19% | +$923M | 0.82% | 17 |
|
|
2019
Q4 | $5.04B | Buy |
24,646,957
+799,899
| +3% | +$147M | 0.65% | 29 |
|
|
2019
Q3 | $3.62B | Sell |
23,847,058
-4,091,650
| -15% | -$666M | 0.51% | 38 |
|
|
2019
Q2 | $4.4B | Sell |
27,938,708
-2,417,017
| -8% | -$379M | 0.62% | 28 |
|
|
2019
Q1 | $4.88B | Buy |
30,355,725
+2,922,288
| +11% | +$534M | 0.72% | 20 |
|
|
2018
Q4 | $5.21B | Buy |
27,433,437
+4,214,711
| +18% | +$879M | 0.88% | 13 |
|
|
2018
Q3 | $4.84B | Buy |
23,218,726
+5,590,272
| +32% | +$1.04B | 0.71% | 18 |
|
|
2018
Q2 | $3B | Buy |
17,628,454
+603,484
| +4% | +$104M | 0.46% | 42 |
|
|
2018
Q1 | $2.86B | Sell |
17,024,970
-731,599
| -4% | -$142M | 0.45% | 43 |
|
|
2017
Q4 | $3.61B | Buy |
17,756,569
+668,042
| +4% | +$133M | 0.59% | 28 |
|
|
2017
Q3 | $3.19B | Buy |
17,088,527
+1,151,213
| +7% | +$205M | 0.55% | 32 |
|
|
2017
Q2 | $2.67B | Buy |
15,937,314
+1,654,367
| +12% | +$266M | 0.48% | 38 |
|
|
2017
Q1 | $2.09B | Buy |
14,282,947
+661,269
| +5% | +$97.4M | 0.39% | 56 |
|
|
2016
Q4 | $1.82B | Sell |
13,621,678
-274,825
| -2% | -$36M | 0.36% | 69 |
|
|
2016
Q3 | $1.81B | Buy |
13,896,503
+2,180,508
| +19% | +$285M | 0.36% | 65 |
|
|
2016
Q2 | $1.5B | Sell |
11,715,995
-2,332,142
| -17% | -$308M | 0.32% | 67 |
|
|
2016
Q1 | $1.93B | Buy |
14,048,137
+1,264,724
| +10% | +$174M | 0.41% | 48 |
|
|
2015
Q4 | $1.87B | Sell |
12,783,413
-2,471,781
| -16% | -$340M | 0.39% | 57 |
|
|
2015
Q3 | $2.06B | Sell |
15,255,194
-4,289,766
| -22% | -$623M | 0.46% | 46 |
|
|
2015
Q2 | $3.17B | Buy |
19,544,960
+10,392,168
| +114% | +$1.44B | 0.65% | 25 |
|
|
2015
Q1 | $1.18B | Buy |
9,152,792
+158,913
| +2% | +$18.5M | 0.24% | 102 |
|
|
2014
Q4 | $926M | Buy |
8,993,879
+3,421,735
| +61% | +$337M | 0.2% | 129 |
|
|
2014
Q3 | $505M | Buy |
5,572,144
+1,491,135
| +37% | +$139M | 0.11% | 219 |
|
|
2014
Q2 | $375M | Buy |
4,081,009
+318,810
| +8% | +$27.3M | 0.08% | 289 |
|
|
2014
Q1 | $315M | Sell |
3,762,199
-757,861
| -17% | -$62.4M | 0.07% | 321 |
|
|
2013
Q4 | $395M | Buy |
4,520,060
+103,950
| +2% | +$8.5M | 0.09% | 267 |
|
|
2013
Q3 | $339M | Buy |
4,416,110
+183,680
| +4% | +$14.3M | 0.08% | 278 |
|
|
2013
Q2 | $307M | Buy |
+4,232,430
| New | +$285M | 0.08% | 294 |
|
Other funds holding CI
VCM
VPM
T. Rowe Price Associates's CI Position: Q1 2026 in Review
T. Rowe Price Associates reduced its Cigna (CI) stake by 59% in Q1 2026, selling an estimated $1.02B and leaving 2,572,843 shares worth $686M. The position accounts for 0.08% of the portfolio, ranked #201.
T. Rowe Price Associates first reported a position in CI in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.81B in Q1 2021. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- T. Rowe Price Associates held 2,572,843 shares of Cigna worth $686M as of Q1 2026.
- T. Rowe Price Associates sold 3,697,370 Cigna shares in Q1 2026, an estimated $1.02B.
- Cigna made up 0.08% of T. Rowe Price Associates's portfolio in Q1 2026, its #201 holding.
- T. Rowe Price Associates first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Cigna position peaked at $6.81B in Q1 2021.
- 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.